Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1 EUR
216.38 M EUR
4.13 B EUR
123.02 M
About GALDERMA GROUP N
Sector
Industry
CEO
Flemming Ørnskov
Website
Headquarters
Zug
Founded
1981
ISIN
CH1335392721
FIGI
BBG01TT1N602
Galderma Group AG engages in the provision of science-based premium dermatology solutions. The firm is also involved in delivering a synergistic portfolio of flagship brands spanning the full spectrum of the fast-growing self-care dermatology market. The company was founded in 1981 and is headquartered in Zug, Switzerland.
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
The current price of 1GALD is 102 EUR — it hasn't changed in the past 24 hours. Watch GALDERMA GROUP N stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange GALDERMA GROUP N stocks are traded under the ticker 1GALD.
1GALD stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in GALDERMA GROUP N price.
We've gathered analysts' opinions on GALDERMA GROUP N future price: according to them, 1GALD price has a max estimate of 122.79 EUR and a min estimate of 105.91 EUR. Watch 1GALD chart and read a more detailed GALDERMA GROUP N stock forecast: see what analysts think of GALDERMA GROUP N and suggest that you do with its stocks.
1GALD stock is 0.00% volatile and has beta coefficient of 0.97. Track GALDERMA GROUP N stock price on the chart and check out the list of the most volatile stocks — is GALDERMA GROUP N there?
Yes, you can track GALDERMA GROUP N financials in yearly and quarterly reports right on TradingView.
GALDERMA GROUP N is going to release the next earnings report on Jul 24, 2025. Keep track of upcoming events with our Earnings Calendar.
1GALD earnings for the last half-year are 1.16 EUR per share, whereas the estimation was 0.86 EUR, resulting in a 34.83% surprise. The estimated earnings for the next half-year are 1.10 EUR per share. See more details about GALDERMA GROUP N earnings.
GALDERMA GROUP N revenue for the last half-year amounts to 2.13 B EUR, despite the estimated figure of 2.14 B EUR. In the next half-year revenue is expected to reach 2.09 B EUR.
1GALD net income for the last half-year is 170.63 M EUR, while the previous report showed 43.42 M EUR of net income which accounts for 292.97% change. Track more GALDERMA GROUP N financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GALDERMA GROUP N EBITDA is 881.03 M EUR, and current EBITDA margin is 21.34%. See more stats in GALDERMA GROUP N financial statements.
Like other stocks, 1GALD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GALDERMA GROUP N stock right from TradingView charts — choose your broker and connect to your account.